Abstract:Transforming growth factor-beta (TGF-beta) elicits cellular effects by activating specific Smad proteins that control the transcription of target genes. Whereas there is growing evidence that there are TGF-beta type I receptor-initiated intracellular pathways that are distinct from the pivotal Smad pathway, their physiological importance in TGF-beta signaling is not well understood. Therefore, we generated TGF-beta type I receptors (also termed ALK5s) with mutations in the L45 loop of the kinase domain, termed ALK5(D266A) and ALK5(3A). These mutants showed retained kinase activity but were unable to activate Smads. Characterization of their signaling properties revealed that the two L45 loop mutants did not mediate Smad-dependent transcriptional responses, TGF-beta-induced growth inhibition, and fibronectin and plasminogen activator-1 production in R4-2 mink lung epithelial cells lacking functional ALK5 protein. Mutation in the L45 loop region did not affect the binding of inhibitory Smads but did abrogate the weak binding of X-linked inhibitor of apoptosis protein and Disabled-2 to ALK5. This suggests that the L45 loop in the kinase domain is important for docking of other binding proteins. Interestingly, JNK MAP kinase activity was found to be activated by the ALK5(3A) mutant in various cell types. In addition, TGF-beta-induced inhibition of cyclin D1 expression and stimulation of PMEPA1 (androgen-regulated prostatic mRNA) expression were found to occur, albeit weakly, in an Smad-independent manner in normal murine mammary gland cells. However, the TGF-beta-induced epithelial to mesenchymal transdifferentiation was found to require an intact L45 loop and is likely to be dependent on the Smad pathways.

Determinants of Specificity in Tgf-Beta Signal Transduction

Specificity and versatility in tgf-beta signaling through Smads.

The L45 Loop in Type I Receptors for Tgf-Beta Family Members is A Critical Determinant in Specifying Smad Isoform Activation

Post-translational regulation of TGF-β receptor and Smad signaling.

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Specificity, Diversity, and Regulation in TGF-beta Superfamily Signaling.

Posttranslational Regulation of Smads

A Kinase Subdomain of Transforming Growth Factor-Beta (Tgf-Beta) Type I Receptor Determines the Tgf-Beta Intracellular Signaling Specificity

Signaling Inputs Converge On Nuclear Effecters In Tgf-Beta Signaling

New Insights into TGF-β–Smad Signalling

Negative Regulation of TGF-β Receptor/smad Signal Transduction

Smad2 and Smad3 Have Differential Sensitivity in Relaying TGFβ Signaling and Inversely Regulate Early Lineage Specification

Transcriptional regulators ensuring specific gene expression and decision-making at high TGF{beta} doses

TGF-β Signaling from Receptors to Smads

Signaling Inputs Converge on Nuclear Effectors in TGF-β Signaling

Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators

Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

Axin and GSK3- Control Smad3 Protein Stability and Modulate TGF- Signaling.

Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors